IN2012DN02828A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02828A IN2012DN02828A IN2828DEN2012A IN2012DN02828A IN 2012DN02828 A IN2012DN02828 A IN 2012DN02828A IN 2828DEN2012 A IN2828DEN2012 A IN 2828DEN2012A IN 2012DN02828 A IN2012DN02828 A IN 2012DN02828A
- Authority
- IN
- India
- Prior art keywords
- vildagliptin
- complexes
- present
- amorphous
- high purity
- Prior art date
Links
- SYOKIDBDQMKNDQ-XWTIBIIYSA-N vildagliptin Chemical class C1C(O)(C2)CC(C3)CC1CC32NCC(=O)N1CCC[C@H]1C#N SYOKIDBDQMKNDQ-XWTIBIIYSA-N 0.000 abstract 7
- 229960001254 vildagliptin Drugs 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
The present invention relates to the use of novel vildagliptin complexes for the manufacture of high purity vildagliptin of Formula I and/or pharmaceutical acceptable salts thereof. Further objects of the present invention are pharmaceutically acceptable complexes of vildagliptin and/or amorphous and crystalline forms, anhydrous forms, amorphous and crystalline hydrates, amorphous and crystalline solvates of the complexes and a process for the preparation thereof. Another object of the present invention is the high purity vildagliptin and pharmaceutically acceptable salts thereof prepared form the vildagliptin complexes of the present invention, a process for the preparation thereof and pharmaceutical compositions containing vildagliptin base, pharmaceutically acceptable salts and/or complexes and use thereof for the treatment of type 2 diabetes (NIDDM). The present invention provides pharmaceutically advantageous high purity vildagliptin complexes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0900638A HUP0900638A2 (en) | 2009-10-07 | 2009-10-07 | Adducts of inorganic salts basea on vildaelitpin applicable for preparation of pharmaceutical compositions |
| PCT/HU2010/000106 WO2011042765A1 (en) | 2009-10-07 | 2010-10-07 | Inorganic salt complexes of vildagliptin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN02828A true IN2012DN02828A (en) | 2015-07-24 |
Family
ID=89989301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2828DEN2012 IN2012DN02828A (en) | 2009-10-07 | 2010-10-07 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8877799B2 (en) |
| EP (1) | EP2486008B1 (en) |
| CN (1) | CN102656144A (en) |
| BR (1) | BR112012008007A2 (en) |
| CA (1) | CA2776005A1 (en) |
| EA (1) | EA021810B1 (en) |
| HU (1) | HUP0900638A2 (en) |
| IN (1) | IN2012DN02828A (en) |
| WO (1) | WO2011042765A1 (en) |
| ZA (1) | ZA201202464B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU231050B1 (en) | 2010-08-19 | 2020-02-28 | Egis Gyógyszergyár Nyrt. | Process for the preparation of a pharmaceutical active ingredient |
| CN103724248B (en) * | 2014-01-16 | 2018-07-27 | 万全万特制药江苏有限公司 | The preparation method of vildagliptin process contaminants |
| CN104644582A (en) * | 2014-12-14 | 2015-05-27 | 天津市康瑞药业有限公司 | Vildagliptin dropping pill and preparation method thereof |
| CN105330580B (en) * | 2015-10-27 | 2017-12-12 | 石家庄康贺威药业有限公司 | A kind of vildagliptin compound and preparation method thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO5150173A1 (en) | 1998-12-10 | 2002-04-29 | Novartis Ag | COMPOUNDS N- (REPLACED GLYCLE) -2-DIPEPTIDYL-IV PEPTIDASE INHIBITING CYANOPIRROLIDINS (DPP-IV) WHICH ARE EFFECTIVE IN THE TREATMENT OF CONDITIONS MEDIATED BY DPP-IV INHIBITION |
| PE20050021A1 (en) | 2003-04-16 | 2005-03-15 | Novartis Ag | PROCEDURE FOR THE PREPARATION OF N-SUBSTITUTED 2-CYANOPYRROLIDINE |
| GB0308854D0 (en) * | 2003-04-16 | 2003-05-21 | Novartis Ag | Organic compounds |
| JP2009503108A (en) | 2005-08-04 | 2009-01-29 | ノバルティス アクチエンゲゼルシャフト | Vildagliptin salt |
| WO2008084383A2 (en) | 2007-01-10 | 2008-07-17 | Medichem, S.A. | Process for preparing vildagliptin |
-
2009
- 2009-10-07 HU HU0900638A patent/HUP0900638A2/en not_active IP Right Cessation
-
2010
- 2010-10-07 EP EP10773700.9A patent/EP2486008B1/en active Active
- 2010-10-07 CA CA2776005A patent/CA2776005A1/en not_active Abandoned
- 2010-10-07 WO PCT/HU2010/000106 patent/WO2011042765A1/en active Application Filing
- 2010-10-07 EA EA201290156A patent/EA021810B1/en not_active IP Right Cessation
- 2010-10-07 US US13/500,356 patent/US8877799B2/en not_active Expired - Fee Related
- 2010-10-07 CN CN2010800493564A patent/CN102656144A/en active Pending
- 2010-10-07 BR BR112012008007A patent/BR112012008007A2/en not_active IP Right Cessation
- 2010-10-07 IN IN2828DEN2012 patent/IN2012DN02828A/en unknown
-
2012
- 2012-04-04 ZA ZA2012/02464A patent/ZA201202464B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8877799B2 (en) | 2014-11-04 |
| ZA201202464B (en) | 2013-06-26 |
| EP2486008B1 (en) | 2015-07-29 |
| HUP0900638A2 (en) | 2011-05-30 |
| HU0900638D0 (en) | 2010-03-01 |
| CA2776005A1 (en) | 2011-04-14 |
| WO2011042765A1 (en) | 2011-04-14 |
| US20130005790A1 (en) | 2013-01-03 |
| CN102656144A (en) | 2012-09-05 |
| EA201290156A1 (en) | 2012-11-30 |
| EA021810B1 (en) | 2015-09-30 |
| EP2486008A1 (en) | 2012-08-15 |
| WO2011042765A8 (en) | 2012-06-14 |
| BR112012008007A2 (en) | 2016-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20125579B (en) | Novel crystalline form vi of agomelatine, preparation method thereof and pharmaceutical compositions containing same | |
| UA83718C2 (en) | New crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| MY149731A (en) | Compounds | |
| TW200716511A (en) | New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it | |
| UA105671C2 (en) | Quinoline derivative-containing pharmaceutical composition | |
| GEP20105086B (en) | Potassium salt of an hiv integrase inhibitor | |
| MX2013000295A (en) | Process of preparing a thrombin specific inhibitor. | |
| MX2011011661A (en) | Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750. | |
| UA83720C2 (en) | New cyrstalline form v of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| PL2018379T3 (en) | Scopine salts and their use in processes for the preparation of n-demethyl-tiotropium and tiotropium bromide | |
| MY160460A (en) | Agomelatine hydrochloride hydrate and preparation thereof | |
| GEP20094576B (en) | New cyrstalline form iii of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| PT2323972E (en) | C7-fluoro substituted tetracycline compounds | |
| SG179031A1 (en) | Hsl inhibitors useful in the treatment of diabetes | |
| PH12015502429A1 (en) | Dicarboxylic acid compound | |
| IN2012DN02828A (en) | ||
| MY161749A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
| MY147951A (en) | Crystalline potassium salt of lipoxin a? analogs | |
| MX2013002620A (en) | Novel n-hydroxy-benzamides for the treatment of cancer. | |
| IN2012DN01292A (en) | ||
| MX2012000685A (en) | 3-phenoxymethylpyrrolidine compounds. | |
| MY195576A (en) | Novel Amino-Imidazopyridine Derivatives as Janus Kinase Inhibitors and Pharmaceutical use Thereof | |
| MX2009012518A (en) | 4,4-disubstituted piperidine derivatives. | |
| MY157492A (en) | Pharmaceutical composition 271 | |
| MX2013000294A (en) | Intermediates and process for preparing a thrombin specific inhibitor. |